Analysis of membrane receptor of aralin, a cancer-selective cytotoxic protein from aralin elata
Analysis of membrane receptor of aralin, a cancer-selective cytotoxic protein from aralin elata
批准号:
23701104
负责人:
AKIYAMA Hirotada
金额:
$2.58万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Young Scientists (B)
财政年份:
2011
资助国家:
日本
项目状态:
已结题
起止时间:
2011 至 2012
中文摘要
木本植物Aralin是一种新型II型核糖体失活蛋白(RIP)。它的a链表现出RNA n -糖苷酶活性,使核糖体失活,抑制蛋白质合成,而b链是Gal及其衍生物特异性凝集素。与正常细胞相比,Aralin更倾向于诱导癌细胞凋亡。为了确定有效的aralin受体,我们之前用抗aralin抗体的far Western blotting和LC/MS分析了膜蛋白。结果表明,aralin受体为110 kda高密度脂蛋白结合蛋白(HDLBP),由150 kda高密度脂蛋白结合蛋白加工而成,作为一种活性HDL受体存在于脂筏中。110-kDa HDLBP在不同肿瘤细胞中的表达水平均高于正常细胞。此外,我们利用miRNAs构建了110 kda的hdlbp敲低HeLa细胞。这些细胞对aralin的敏感性明显降低。相比之下,仅通过强制表达150-kDa的HDLBP无法获得110-kDa的过表达细胞。预期,这些细胞对aralin的敏感性与对照细胞相当。因此,这些结果表明,加工后的110-kDa HDLBP是真正的受体,其在脂质筏中的表达水平决定了对aralin的敏感性。利用N-和c -末端标记的150-kDa HDLBP对150-kDa到110-kDa活性形态的HDLBP加工分析表明,N-末端区域可以被去除。目前,我们正在寻求鉴定n端切割位点和可能的加工酶。此外,我们正在探索HDLBP影响多种癌细胞的加工机制。
英文摘要
Aralin from Aralia elatais a new type II ribosome inactivating protein (RIP). Its A-chain exhibits RNA N-glycosidase activity to inactivate the ribosome and inhibit protein synthesis, while B-chain is the Gal and its derivatives-specific lectin. Aralin preferentially induces apoptosis in cancer cells compared with normal cells. To identify the potent aralin receptor, we previously analyzed the membrane proteins by far Western blotting with anti-aralin antibody, and LC/MS. The obtained data suggested that aralin receptor is the 110-kDa high density lipoprotein binding protein (HDLBP), which is processed from 150-kDa HDLBP and existing in lipid raft as an active HDL receptor. The expression levels of 110-kDa HDLBP of various cancer cells were higher than those of normal cells. Furthermore, we established 110-kDa HDLBP-knockdown HeLa cells using miRNAs. The sensitivity of these cells against aralin was robustly reduced. In contrast, 110-kDa HDLBP-over-expressing cells were not obtained by only forced expression of 150-kDa HDLBP. Expectedly, sensitivity of these cells against aralin was comparable to the control cells. Thus, these results indicate that the processed 110-kDa HDLBP is the authentic receptor and its expression level in the lipid raft determines the sensitivity toward aralin. HDLBP processing analysis from 150-kDa to 110-kDa active form using N- and C-terminal-tagged 150-kDa HDLBP indicated that the N-terminal region could be removed. Currently, we were pursuing the identification of the N-terminal cutting site and possible processing enzymes. In addition, we are exploring the processing mechanism of the HDLBP affecting variety of cancer cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Establishment of the highly sensitive detection method of cancer cells under near infrared excitation, and its possible application for cancer therapy
近红外激发下癌细胞高灵敏检测方法的建立及其在癌症治疗中的可能应用
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[Hirotada Akiyama, Akito Hattori, Shogo Hayashi, Kohei Soga, Fumio Tashiro, Hirotada Akiyama]
通讯作者:
Hirotada Akiyama
Ectopic BCAS2 expression causes abnormal amplification of centrosome
BCAS2 异位表达导致中心体异常扩增
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[Shigekazu Murakami, Hirotada Akiyama, Fumio Tashiro]
通讯作者:
Fumio Tashiro
Analysis of membrane receptor of aralin, a cancer-selective cytotoxic protein from aralin elata
阿拉林 (aralin elata) 的癌症选择性细胞毒性蛋白膜受体的分析
DOI:
--
发表时间:
期刊:
影响因子:
--
作者:
[Hirotada Akiyama, Akito Hattori, Shogo Hayashi, Kohei Soga, Fumio Tashiro, Hirotada Akiyama, Hiroko Otsuka]
通讯作者:
Hiroko Otsuka
DOI:
10.1371/journal.pone.0056997
发表时间:
2013
期刊:
PloS one
影响因子:
3.7
作者:
[Yamada T, Urano-Tashiro Y, Tanaka S, Akiyama H, Tashiro F]
通讯作者:
Tashiro F
ヒト肝癌細胞において性決定因子 SRY はstemness factors の転写制御を介して癌幹細胞の性質を維持する
在人类肝癌细胞中,性别决定因子 SRY 通过干性因子的转录调节维持癌症干细胞特性。
DOI:
--
发表时间:
2012
期刊:
影响因子:
--
作者:
[坂本依里奈, 村上重和, 上元寿人, 加藤康平, 茂木南士, 二宮航, 日笠里英, 柴田龍弘, 秋山弘匡, 田代文夫]
通讯作者:
田代文夫
共 13 条
海外基金